Cancer patients’ experiences with immune checkpoint modulators: A qualitative study

Cancer patients’ experiences with immune checkpoint modulators: A qualitative study

Abstract Background Minimal qualitative data exist on the experiences of cancer patients treated with immune checkpoint inhibitors or costimulatory antibodies. Understanding the day to day experiences of patients being treated with immune checkpoint modulators, and how these relate to their health‐r...

Full description

Bibliographic Details
Main Authors: Kari Ala‐Leppilampi, Natalie A. Baker, Chris McKillop, Marcus O. Butler, Lillian L. Siu, Anna Spreafico, Albiruni R. Abdul Razak, Anthony M. Joshua, David Hogg, Philippe L. Bedard, Natasha Leighl, Amit M. Oza, Janet A. Parsons, Aaron R. Hansen
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Cancer Medicine
Subjects:
costimulatory antibodies
Health‐related quality of life
immune checkpoint inhibitors
immunotherapy
patient experiences
Online Access:https://doi.org/10.1002/cam4.2940

Internet

https://doi.org/10.1002/cam4.2940

Similar Items